 BRISBANE, Calif.--BUSINESS WIRE--Sangamo Therapeutics, Inc. Nasdaq: SGMO, a genomic medicine company, announced today that the Company has scheduled the release of its third quarter 2021 financial results on Thursday, November 4, 2021. The press release will be followed by a conference call at 9:15 a.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide business and clinical updates. The confe 